ResearcherJohns Hopkins UniversityNo recent work listed

Yong Wu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3764-3846; OpenAlex author ID A5028160312. Sources: OpenAlex.

Their work

Papers: 3 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 14

Papers, trials and grants by year

2019: 1 paper · 2020: 1 paper · 2021: none · 2022: 1 paper

Papers 3

The Pre-Ablation Circulating Tumor-Associated Inflammatory Index Predicts the Prognosis of Patients with Liver Metastasis from Pancreatic Cancer. Co-author DOI 10.2147/jir.s381807 ↗
LncRNA FAM66C inhibits pancreatic cancer progression by sponging miR-574-3p. Last author DOI 10.21037/tcr.2020.02.24 ↗
Genetic landscape of prognostic value in pancreatic ductal adenocarcinoma microenvironment. Co-author DOI 10.21037/atm.2019.10.91 ↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Linjia Peng · 1 shared paper, 2022 · strength 0.19
- Paper The Pre-Ablation Circulating Tumor-Associated Inflammatory Index Predicts the Prognosis of Patients with Liver Metastas… DOI 10.2147/jir.s381807 ↗
Huifeng Gao · 1 shared paper, 2022 · strength 0.19
- Paper The Pre-Ablation Circulating Tumor-Associated Inflammatory Index Predicts the Prognosis of Patients with Liver Metastas… DOI 10.2147/jir.s381807 ↗
Yujie Li · 1 shared paper, 2022 · strength 0.19
- Paper The Pre-Ablation Circulating Tumor-Associated Inflammatory Index Predicts the Prognosis of Patients with Liver Metastas… DOI 10.2147/jir.s381807 ↗
Hao Chen · 1 shared paper, 2022 · strength 0.19
- Paper The Pre-Ablation Circulating Tumor-Associated Inflammatory Index Predicts the Prognosis of Patients with Liver Metastas… DOI 10.2147/jir.s381807 ↗
Jiangang Zhu · 1 shared paper, 2020 · strength 0.16
- Paper LncRNA FAM66C inhibits pancreatic cancer progression by sponging miR-574-3p. DOI 10.21037/tcr.2020.02.24 ↗
Shimpei Maeda · 1 shared paper, 2019 · strength 0.08
- Paper Genetic landscape of prognostic value in pancreatic ductal adenocarcinoma microenvironment. DOI 10.21037/atm.2019.10.91 ↗
Lingdi Yin · 1 shared paper, 2019 · strength 0.08
- Paper Genetic landscape of prognostic value in pancreatic ductal adenocarcinoma microenvironment. DOI 10.21037/atm.2019.10.91 ↗
Ning Pu · 1 shared paper, 2019 · strength 0.08
- Paper Genetic landscape of prognostic value in pancreatic ductal adenocarcinoma microenvironment. DOI 10.21037/atm.2019.10.91 ↗
Qiangda Chen · 1 shared paper, 2019 · strength 0.08
- Paper Genetic landscape of prognostic value in pancreatic ductal adenocarcinoma microenvironment. DOI 10.21037/atm.2019.10.91 ↗
Shanshan Gao · 1 shared paper, 2019 · strength 0.08
- Paper Genetic landscape of prognostic value in pancreatic ductal adenocarcinoma microenvironment. DOI 10.21037/atm.2019.10.91 ↗
Wenhui Lou · 1 shared paper, 2019 · strength 0.08
- Paper Genetic landscape of prognostic value in pancreatic ductal adenocarcinoma microenvironment. DOI 10.21037/atm.2019.10.91 ↗
Yayun Zhu · 1 shared paper, 2019 · strength 0.08
- Paper Genetic landscape of prognostic value in pancreatic ductal adenocarcinoma microenvironment. DOI 10.21037/atm.2019.10.91 ↗
Hai‐Jie Hu · 1 shared paper, 2019 · strength 0.08
- Paper Genetic landscape of prognostic value in pancreatic ductal adenocarcinoma microenvironment. DOI 10.21037/atm.2019.10.91 ↗
Wenchuan Wu · 1 shared paper, 2019 · strength 0.08
- Paper Genetic landscape of prognostic value in pancreatic ductal adenocarcinoma microenvironment. DOI 10.21037/atm.2019.10.91 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.